Institute of Organic Chemistry and Biochemistry
Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences (shortened as IOCB Prague) (Czech: Ústav organické chemie a biochemie Akademie věd České republiky) is a research institute under the Czech Academy of Sciences (CAS). The institute centers around research in the fields of organic chemistry, biochemistry and neighboring disciplines, mostly oriented at applications in medicine and environment. It is known for its contribution in the development of key drugs against HIV and HBV. The institute also takes part in university education, supervising master's and doctoral theses.
Ústav organické chemie a biochemie Akademie věd České republiky | |
Other name | IOCB Prague, ÚOCHB |
---|---|
Type | Public research institution |
Established | 1953 |
Budget | USD 60 mil. |
Director | Jan Konvalinka |
Total staff | ~950 |
Undergraduates | ~80 |
~230 | |
Location | Prague , |
Website | www.uochb.cz |
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.